×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!

China's Role as a Development Hotspot for Biopharmaceutical Companies

November 19, 2012
Dr. Karen Chu, Corporate VP of Project Leadership Asia Pacific, PAREXEL explains China's role as a development hot spot for the biopharma industry. Learn the size of the Chinese market and its projected growth. Dr. Chu will help you understand China's investment in infrastructure and training to capitalize on this growth, and the key challenges that newcomers should address when including China as part of their Global drug development plan.
Previous Video
Alberto Grignolo, PhD Speaks on Regulatory Landscape in Japan Over the Next 5 Years
Alberto Grignolo, PhD Speaks on Regulatory Landscape in Japan Over the Next 5 Years

Alberto Grignolo, PhD speaks on the regulatory landscape in Japan over the next 5 years. He talks about the...

Next Video
Nakamori
Nakamori